Clinical Development

(Image: Getty/BernardaSv)

India-based CRO completes second successful audit

By Melissa Fassbender

The India-based CRO Veeda Clinical Research has completed a second audit by the Malaysia Regulatory Agency, following 18 US FDA inspections over the past two years.

(Image: Getty/microgen)

PCI adds new facility for clinical trial returns

By Maggie Lynch

An additional investment at the PCI clinical services’ site brought forth an expansion to support the return of investigational drug products used in clinical trials.

(Image: Getty/Image Source)

Novotech acquires specialty CRO to expand services in Asia-Pacific

By Melissa Fassbender

Novotech has acquired a CRO to further support its customers’ clinical research programs across different phases and countries in Asia-Pacific – an area in which it has 10 partnership agreements providing access to more than 1.4bn people.

People on the Move: Outsourcing-Pharma roundup September '18

People on the Move: Outsourcing-Pharma roundup September '18

By Melissa Fassbender

Metrion has bolstered its drug discovery leadership team, CluePoints has upped its RBM services, and Concept Life Sciences has added to its analytical services division, among other moves this month in the outsourced pharmaceutical services industry.

(Image: Getty/RamCreativ)

Quanticate taps CluePoints for data quality oversight

By Melissa Fassbender

Quanticate is using CluePoints’ software to perform data integrity checks on all types of monitoring and investigator site data as part of its new Data Quality Oversight service.

(Image: Getty/RamCreativ)

Infographic: Pivotal clinical trial costs

By Melissa Fassbender

Clinical trials that support FDA approvals of new drugs have a median cost of $19m – representing less than one percent of the average drug development cost, which is estimated at between $2 and $3bn.

Follow us

Products

View more

Webinars